{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.3616.200.110.102.10002",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2022-12-06T01:03:37.000-05:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "Clinical Architecture"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2023-06-21"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2022-12-06"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.10002",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.3616.200.110.102.10002"
  }],
  "version" : "20221206",
  "name" : "SARSCoV2VaccinesBivalent",
  "title" : "SARS CoV 2 Vaccines, Bivalent",
  "status" : "active",
  "experimental" : false,
  "date" : "2023-06-21T18:16:37-04:00",
  "publisher" : "Clinical Architecture",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: This set of values contains terms related to),(Data Element Scope: ),(Inclusion Criteria: Includes),(Exclusion Criteria: Excludes)",
  "compose" : {
    "include" : [{
      "system" : "http://hl7.org/fhir/sid/cvx",
      "concept" : [{
        "code" : "229",
        "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose"
      },
      {
        "code" : "300",
        "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation"
      },
      {
        "code" : "301",
        "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:b3c71030-1ed8-4b33-9476-52cd345aaee9",
    "timestamp" : "2023-09-26T13:03:12-04:00",
    "total" : 3,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://hl7.org/fhir/sid/cvx",
      "version" : "20230725",
      "code" : "229",
      "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose"
    },
    {
      "system" : "http://hl7.org/fhir/sid/cvx",
      "version" : "20230725",
      "code" : "300",
      "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation"
    },
    {
      "system" : "http://hl7.org/fhir/sid/cvx",
      "version" : "20230725",
      "code" : "301",
      "display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation"
    }]
  }
}